Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Artrya Limited ( (AU:AYA) ) has provided an announcement.
Artrya Limited announced the application for the quotation of 1,250,000 fully paid ordinary securities on the Australian Securities Exchange (ASX) under the code AYA. This move is part of the company’s ongoing efforts to enhance its market presence and provide liquidity to its stakeholders, potentially impacting its operational capabilities and industry positioning positively.
The most recent analyst rating on (AU:AYA) stock is a Buy with a A$2.87 price target. To see the full list of analyst forecasts on Artrya Limited stock, see the AU:AYA Stock Forecast page.
More about Artrya Limited
Artrya Limited operates in the healthcare industry, focusing on developing innovative medical technology solutions. The company specializes in creating software for the detection and management of coronary artery disease, aiming to improve patient outcomes and streamline clinical workflows.
Average Trading Volume: 395,149
Technical Sentiment Signal: Buy
For an in-depth examination of AYA stock, go to TipRanks’ Overview page.